Advertisement

Ads Placeholder
Loading...

BZAM Ltd.

Z6A.FXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
0.01
0.00(0.00%)
German Market opens in 1h 3m

BZAM Ltd. Fundamental Analysis

BZAM Ltd. (Z6A.F) shows weak financial fundamentals with a PE ratio of -0.06, profit margin of -71.94%, and ROE of -22.96%. The company generates $0.2B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position358.24%
PEG Ratio-0.00
Current Ratio2.08

Areas of Concern

ROE-22.96%
Operating Margin-71.40%
We analyze Z6A.F's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -62.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-62.1/100

We analyze Z6A.F's fundamental strength across five key dimensions:

Efficiency Score

Weak

Z6A.F struggles to generate sufficient returns from assets.

ROA > 10%
-12.94%

Valuation Score

Excellent

Z6A.F trades at attractive valuation levels.

PE < 25
-0.06
PEG Ratio < 2
-0.00

Growth Score

Weak

Z6A.F faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

Z6A.F maintains a strong and stable balance sheet.

Debt/Equity < 1
0.26
Current Ratio > 1
2.08

Profitability Score

Weak

Z6A.F struggles to sustain strong margins.

ROE > 15%
-2296.19%
Net Margin ≥ 15%
-71.94%
Positive Free Cash Flow
No

Key Financial Metrics

Is Z6A.F Expensive or Cheap?

P/E Ratio

Z6A.F trades at -0.06 times earnings. This suggests potential undervaluation.

-0.06

PEG Ratio

When adjusting for growth, Z6A.F's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values BZAM Ltd. at 0.01 times its book value. This may indicate undervaluation.

0.01

EV/EBITDA

Enterprise value stands at 1.55 times EBITDA. This is generally considered low.

1.55

How Well Does Z6A.F Make Money?

Net Profit Margin

For every $100 in sales, BZAM Ltd. keeps $-71.94 as profit after all expenses.

-71.94%

Operating Margin

Core operations generate -71.40 in profit for every $100 in revenue, before interest and taxes.

-71.40%

ROE

Management delivers $-22.96 in profit for every $100 of shareholder equity.

-22.96%

ROA

BZAM Ltd. generates $-12.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

-12.94%

Following the Money - Real Cash Generation

Operating Cash Flow

BZAM Ltd. generates limited operating cash flow of $-31.33M, signaling weaker underlying cash strength.

$-31.33M

Free Cash Flow

BZAM Ltd. generates weak or negative free cash flow of $-35.24M, restricting financial flexibility.

$-35.24M

FCF Per Share

Each share generates $-0.12 in free cash annually.

$-0.12

FCF Yield

Z6A.F converts -1.39% of its market value into free cash.

-1.39%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.01

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.15

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.26

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.08

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.23

vs 25 benchmark

ROA

Return on assets percentage

-0.13

vs 25 benchmark

ROCE

Return on capital employed

-0.15

vs 25 benchmark

How Z6A.F Stacks Against Its Sector Peers

MetricZ6A.F ValueSector AveragePerformance
P/E Ratio-0.0628.54 Better (Cheaper)
ROE-22.96%738.00% Weak
Net Margin-71.94%-43982.00% (disorted) Weak
Debt/Equity0.260.34 Strong (Low Leverage)
Current Ratio2.082806.01 Strong Liquidity
ROA-12.94%-14624.00% (disorted) Weak

Z6A.F outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews BZAM Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ